(1->4)-beta-D-glucan multiple interactions ISO Rps6ka1 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of RPS6KA1 mRNA CTD PMID:36331819 (20R)-protopanaxadiol increases expression ISO RPS6KA1 (Homo sapiens) 6480464 protopanaxadiol results in increased expression of RPS6KA1 mRNA CTD PMID:31805304 1,2-dimethylhydrazine multiple interactions ISO Rps6ka1 (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of RPS6KA1 mRNA CTD PMID:22206623 1,2-dimethylhydrazine affects expression ISO Rps6ka1 (Mus musculus) 6480464 1 and 2-Dimethylhydrazine affects the expression of RPS6KA1 mRNA CTD PMID:22206623 1-chloro-2,4-dinitrobenzene affects binding ISO RPS6KA1 (Homo sapiens) 6480464 Dinitrochlorobenzene binds to RPS6KA1 protein CTD PMID:32991956 15-deoxy-Delta(12,14)-prostaglandin J2 multiple interactions ISO Rps6ka1 (Mus musculus) 6480464 [15-deoxy-delta(12 and 14)-prostaglandin J2 co-treated with alitretinoin] results in decreased phosphorylation of RPS6KA1 protein CTD PMID:16611854 17alpha-ethynylestradiol increases expression ISO Rps6ka1 (Mus musculus) 6480464 Ethinyl Estradiol results in increased expression of RPS6KA1 mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Rps6ka1 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of RPS6KA1 mRNA CTD PMID:21570461 and PMID:26377647 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of RPS6KA1 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of RPS6KA1 mRNA CTD PMID:32109520 2-palmitoylglycerol increases expression ISO RPS6KA1 (Homo sapiens) 6480464 2-palmitoylglycerol results in increased expression of RPS6KA1 mRNA CTD PMID:37199045 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of RPS6KA1 mRNA CTD PMID:30047161 9-cis-retinoic acid multiple interactions ISO Rps6ka1 (Mus musculus) 6480464 [15-deoxy-delta(12 and 14)-prostaglandin J2 co-treated with Alitretinoin] results in decreased phosphorylation of RPS6KA1 protein CTD PMID:16611854 acrolein multiple interactions ISO RPS6KA1 (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of RPS6KA1 mRNA more ... CTD PMID:32699268 and PMID:32845096 acrylamide decreases expression ISO RPS6KA1 (Homo sapiens) 6480464 Acrylamide results in decreased expression of RPS6KA1 mRNA CTD PMID:32763439 aflatoxin B1 increases expression ISO RPS6KA1 (Homo sapiens) 6480464 Aflatoxin B1 results in increased expression of RPS6KA1 mRNA CTD PMID:22100608 all-trans-retinoic acid multiple interactions ISO RPS6KA1 (Homo sapiens) 6480464 RPS6KA1 protein promotes the reaction [Tretinoin results in increased phosphorylation of CREB1 protein] CTD PMID:16280361 all-trans-retinoic acid increases expression ISO RPS6KA1 (Homo sapiens) 6480464 Tretinoin results in increased expression of RPS6KA1 mRNA CTD PMID:33167477 alpha-pinene multiple interactions ISO RPS6KA1 (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of RPS6KA1 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of RPS6KA1 mRNA CTD PMID:32699268 amitrole increases expression EXP 6480464 Amitrole results in increased expression of RPS6KA1 mRNA CTD PMID:30047161 antirheumatic drug decreases expression ISO RPS6KA1 (Homo sapiens) 6480464 Antirheumatic Agents results in decreased expression of RPS6KA1 mRNA CTD PMID:24449571 arsenite(3-) decreases expression ISO Rps6ka1 (Mus musculus) 6480464 arsenite results in decreased expression of RPS6KA1 mRNA CTD PMID:33053406 avermectin decreases phosphorylation ISO RPS6KA1 (Homo sapiens) 6480464 avermectin results in decreased phosphorylation of RPS6KA1 protein CTD PMID:33381906 benzo[a]pyrene increases expression ISO RPS6KA1 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased expression of RPS6KA1 mRNA CTD PMID:21632981 benzo[a]pyrene decreases methylation ISO Rps6ka1 (Mus musculus) 6480464 Benzo(a)pyrene results in decreased methylation of RPS6KA1 exon and Benzo(a)pyrene results in decreased methylation of RPS6KA1 intron CTD PMID:27901495 bis(2-chloroethyl) sulfide increases phosphorylation ISO RPS6KA1 (Homo sapiens) 6480464 Mustard Gas results in increased phosphorylation of RPS6KA1 protein CTD PMID:19845377 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of RPS6KA1 mRNA CTD PMID:25181051 and PMID:31771501 bisphenol A increases expression ISO Rps6ka1 (Mus musculus) 6480464 bisphenol A results in increased expression of RPS6KA1 mRNA CTD PMID:32156529 bisphenol A affects methylation EXP 6480464 bisphenol A affects the methylation of RPS6KA1 promoter CTD PMID:27415467 butanal increases expression ISO RPS6KA1 (Homo sapiens) 6480464 butyraldehyde results in increased expression of RPS6KA1 mRNA CTD PMID:26079696 caffeine decreases phosphorylation ISO RPS6KA1 (Homo sapiens) 6480464 Caffeine results in decreased phosphorylation of RPS6KA1 protein CTD PMID:35688186 calcitriol multiple interactions ISO RPS6KA1 (Homo sapiens) 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of RPS6KA1 mRNA CTD PMID:21592394 calcitriol increases expression ISO RPS6KA1 (Homo sapiens) 6480464 Calcitriol results in increased expression of RPS6KA1 mRNA CTD PMID:21592394 and PMID:26485663 cannabidiol increases expression ISO RPS6KA1 (Homo sapiens) 6480464 Cannabidiol results in increased expression of RPS6KA1 mRNA CTD PMID:27918106 carbamazepine affects expression ISO RPS6KA1 (Homo sapiens) 6480464 Carbamazepine affects the expression of RPS6KA1 mRNA CTD PMID:24752500 carbon nanotube decreases expression ISO Rps6ka1 (Mus musculus) 6480464 Nanotubes and Carbon results in decreased expression of RPS6KA1 mRNA CTD PMID:25554681 and PMID:25620056 cisplatin increases phosphorylation ISO RPS6KA1 (Homo sapiens) 6480464 Cisplatin results in increased phosphorylation of RPS6KA1 protein CTD PMID:21742020 cisplatin increases expression ISO RPS6KA1 (Homo sapiens) 6480464 Cisplatin results in increased expression of RPS6KA1 mRNA CTD PMID:27392435 cisplatin multiple interactions ISO RPS6KA1 (Homo sapiens) 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of RPS6KA1 mRNA and U 0126 inhibits the reaction [Cisplatin results in increased phosphorylation of RPS6KA1 protein] CTD PMID:21742020 and PMID:27392435 cobalt dichloride increases expression ISO Rps6ka1 (Mus musculus) 6480464 cobaltous chloride results in increased expression of RPS6KA1 mRNA CTD PMID:21139344 cocaine multiple interactions EXP 6480464 Cocaine promotes the reaction [RPS6KA1 protein binds to CREB1 protein] and Cocaine results in increased phosphorylation of and results in increased activity of RPS6KA1 protein CTD PMID:15470197 copper atom multiple interactions ISO RPS6KA1 (Homo sapiens) 6480464 [Chelating Agents binds to Copper] which results in decreased expression of RPS6KA1 mRNA CTD PMID:30911355 copper(0) multiple interactions ISO RPS6KA1 (Homo sapiens) 6480464 [Chelating Agents binds to Copper] which results in decreased expression of RPS6KA1 mRNA CTD PMID:30911355 cyclosporin A decreases expression ISO RPS6KA1 (Homo sapiens) 6480464 Cyclosporine results in decreased expression of RPS6KA1 mRNA CTD PMID:25562108 and PMID:27989131 deoxynivalenol multiple interactions ISO Rps6ka1 (Mus musculus) 6480464 4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3 more ... CTD PMID:15772366 and PMID:15976193 deoxynivalenol increases phosphorylation ISO Rps6ka1 (Mus musculus) 6480464 deoxynivalenol results in increased phosphorylation of RPS6KA1 protein CTD PMID:15772366 dibutyl phthalate increases expression ISO Rps6ka1 (Mus musculus) 6480464 Dibutyl Phthalate results in increased expression of RPS6KA1 mRNA CTD PMID:17361019 diclofenac affects expression ISO RPS6KA1 (Homo sapiens) 6480464 Diclofenac affects the expression of RPS6KA1 mRNA CTD PMID:24752500 doxorubicin multiple interactions ISO Rps6ka1 (Mus musculus) 6480464 Doxorubicin promotes the reaction [AZD 6244 results in decreased phosphorylation of RPS6KA1 protein] CTD PMID:17876044 elemental selenium multiple interactions ISO RPS6KA1 (Homo sapiens) 6480464 [Selenium co-treated with Vitamin E] results in increased expression of RPS6KA1 mRNA CTD PMID:19244175 elemental selenium increases expression ISO RPS6KA1 (Homo sapiens) 6480464 Selenium results in increased expression of RPS6KA1 mRNA CTD PMID:19244175 enzacamene increases phosphorylation ISO RPS6KA1 (Homo sapiens) 6480464 enzacamene results in increased phosphorylation of RPS6KA1 protein CTD PMID:30597193 enzyme inhibitor multiple interactions ISO RPS6KA1 (Homo sapiens) 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of RPS6KA1 protein CTD PMID:23301498 epoxiconazole decreases expression ISO Rps6ka1 (Mus musculus) 6480464 epoxiconazole results in decreased expression of RPS6KA1 mRNA CTD PMID:35436446 ethanol decreases expression EXP 6480464 Ethanol results in decreased expression of RPS6KA1 mRNA CTD PMID:20655511 ethanol affects response to substance ISO RPS6KA1 (Homo sapiens) 6480464 RPS6KA1 gene SNP affects the susceptibility to Ethanol CTD PMID:29109170 ethanol multiple interactions ISO Rps6ka1 (Mus musculus) 6480464 [Carbon Tetrachloride co-treated with Ethanol] results in increased expression of RPS6KA1 mRNA CTD PMID:30517762 ethyl methanesulfonate increases expression ISO RPS6KA1 (Homo sapiens) 6480464 Ethyl Methanesulfonate results in increased expression of RPS6KA1 mRNA CTD PMID:23649840 fasudil decreases activity ISO RPS6KA1 (Homo sapiens) 6480464 fasudil results in decreased activity of RPS6KA1 protein CTD PMID:10998351 fenthion decreases expression ISO Rps6ka1 (Mus musculus) 6480464 Fenthion results in decreased expression of RPS6KA1 mRNA CTD PMID:34813904 flufenoxuron multiple interactions ISO Rps6ka1 (Mus musculus) 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [flufenoxuron results in decreased phosphorylation of RPS6KA1 protein] and U 0126 inhibits the reaction [flufenoxuron results in decreased phosphorylation of RPS6KA1 protein] CTD PMID:33771252 flufenoxuron decreases phosphorylation ISO Rps6ka1 (Mus musculus) 6480464 flufenoxuron results in decreased phosphorylation of RPS6KA1 protein CTD PMID:33771252 folic acid multiple interactions ISO Rps6ka1 (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of RPS6KA1 mRNA CTD PMID:22206623 folpet decreases expression ISO Rps6ka1 (Mus musculus) 6480464 folpet results in decreased expression of RPS6KA1 mRNA CTD PMID:31558096 formaldehyde increases expression ISO RPS6KA1 (Homo sapiens) 6480464 Formaldehyde results in increased expression of RPS6KA1 mRNA CTD PMID:23649840 FR900359 affects phosphorylation ISO RPS6KA1 (Homo sapiens) 6480464 FR900359 affects the phosphorylation of RPS6KA1 protein CTD PMID:37730182 gallic acid multiple interactions ISO RPS6KA1 (Homo sapiens) 6480464 Gallic Acid inhibits the reaction [TNF protein results in increased phosphorylation of RPS6KA1 protein] CTD PMID:21420233 inulin multiple interactions ISO Rps6ka1 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of RPS6KA1 mRNA CTD PMID:36331819 ivermectin decreases expression ISO RPS6KA1 (Homo sapiens) 6480464 Ivermectin results in decreased expression of RPS6KA1 protein CTD PMID:32959892 letrozole multiple interactions ISO Rps6ka1 (Mus musculus) 6480464 letrozole results in increased expression of and results in increased phosphorylation of RPS6KA1 protein CTD PMID:15967659 lipopolysaccharide decreases expression ISO Rps6ka1 (Mus musculus) 6480464 Lipopolysaccharides results in decreased expression of RPS6KA1 mRNA CTD PMID:12057914 lipopolysaccharide multiple interactions ISO Rps6ka1 (Mus musculus) 6480464 U 0126 inhibits the reaction [Lipopolysaccharides results in increased activity of RPS6KA1 protein] CTD PMID:10998351 lipopolysaccharide increases activity ISO Rps6ka1 (Mus musculus) 6480464 Lipopolysaccharides results in increased activity of RPS6KA1 protein CTD PMID:10998351 LY294002 multiple interactions ISO Rps6ka1 (Mus musculus) 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [flufenoxuron results in decreased phosphorylation of RPS6KA1 protein] CTD PMID:33771252 lycopene decreases expression ISO RPS6KA1 (Homo sapiens) 6480464 lycopene results in decreased expression of RPS6KA1 protein CTD PMID:17337101 methidathion decreases expression ISO Rps6ka1 (Mus musculus) 6480464 methidathion results in decreased expression of RPS6KA1 mRNA CTD PMID:34813904 methyl methanesulfonate increases expression ISO RPS6KA1 (Homo sapiens) 6480464 Methyl Methanesulfonate results in increased expression of RPS6KA1 mRNA CTD PMID:23649840 myricetin multiple interactions ISO Rps6ka1 (Mus musculus) 6480464 myricetin inhibits the reaction [EGF protein results in increased phosphorylation of RPS6KA1 protein] and myricetin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of RPS6KA1 protein] CTD PMID:17693661 N-methyl-4-phenylpyridinium increases expression ISO Rps6ka1 (Mus musculus) 6480464 1-Methyl-4-phenylpyridinium results in increased expression of RPS6KA1 protein CTD PMID:26558463 N-nitrosodiethylamine affects phosphorylation ISO Rps6ka1 (Mus musculus) 6480464 Diethylnitrosamine affects the phosphorylation of RPS6KA1 protein CTD PMID:24535843 N-nitrosodimethylamine increases expression EXP 6480464 Dimethylnitrosamine results in increased expression of RPS6KA1 mRNA and Dimethylnitrosamine results in increased expression of RPS6KA1 protein CTD PMID:17032414 nickel atom decreases expression ISO RPS6KA1 (Homo sapiens) 6480464 Nickel results in decreased expression of RPS6KA1 mRNA CTD PMID:23195993 nickel atom increases expression ISO RPS6KA1 (Homo sapiens) 6480464 Nickel results in increased expression of RPS6KA1 mRNA CTD PMID:24768652 and PMID:25583101 Nodularin increases phosphorylation EXP 6480464 nodularin results in increased phosphorylation of RPS6KA1 protein CTD PMID:25192816 ochratoxin A increases phosphorylation ISO RPS6KA1 (Homo sapiens) 6480464 ochratoxin A results in increased phosphorylation of RPS6KA1 protein CTD PMID:31154016 ozone multiple interactions ISO RPS6KA1 (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of RPS6KA1 mRNA more ... CTD PMID:32699268 more ... paracetamol affects expression ISO Rps6ka1 (Mus musculus) 6480464 Acetaminophen affects the expression of RPS6KA1 mRNA CTD PMID:17562736 paracetamol affects expression ISO RPS6KA1 (Homo sapiens) 6480464 Acetaminophen affects the expression of RPS6KA1 mRNA CTD PMID:25458485 paracetamol increases expression ISO RPS6KA1 (Homo sapiens) 6480464 Acetaminophen results in increased expression of RPS6KA1 mRNA CTD PMID:22230336 perfluorooctane-1-sulfonic acid multiple interactions ISO Rps6ka1 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of RPS6KA1 mRNA and [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of RPS6KA1 mRNA CTD PMID:36331819 phorbol 13-acetate 12-myristate increases phosphorylation ISO Rps6ka1 (Mus musculus) 6480464 Tetradecanoylphorbol Acetate results in increased phosphorylation of RPS6KA1 protein CTD PMID:17693661 phorbol 13-acetate 12-myristate multiple interactions ISO Rps6ka1 (Mus musculus) 6480464 myricetin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of RPS6KA1 protein] CTD PMID:17693661 pioglitazone increases expression ISO RPS6KA1 (Homo sapiens) 6480464 Pioglitazone results in increased expression of RPS6KA1 mRNA CTD PMID:32589349 pirinixic acid multiple interactions ISO Rps6ka1 (Mus musculus) 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of RPS6KA1 mRNA CTD PMID:19710929 pregnenolone 16alpha-carbonitrile decreases expression ISO Rps6ka1 (Mus musculus) 6480464 Pregnenolone Carbonitrile results in decreased expression of RPS6KA1 mRNA CTD PMID:28903501 propiconazole decreases expression ISO Rps6ka1 (Mus musculus) 6480464 propiconazole results in decreased expression of RPS6KA1 mRNA CTD PMID:21278054 propiconazole increases expression EXP 6480464 propiconazole results in increased expression of RPS6KA1 mRNA CTD PMID:30047161 quercetin decreases activity ISO RPS6KA1 (Homo sapiens) 6480464 Quercetin results in decreased activity of RPS6KA1 protein CTD PMID:10998351 quercetin increases expression ISO RPS6KA1 (Homo sapiens) 6480464 Quercetin results in increased expression of RPS6KA1 mRNA CTD PMID:21632981 resveratrol decreases phosphorylation ISO RPS6KA1 (Homo sapiens) 6480464 resveratrol results in decreased phosphorylation of RPS6KA1 protein CTD PMID:16979140 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of RPS6KA1 protein CTD PMID:35544339 selenium atom multiple interactions ISO RPS6KA1 (Homo sapiens) 6480464 [Selenium co-treated with Vitamin E] results in increased expression of RPS6KA1 mRNA CTD PMID:19244175 selenium atom increases expression ISO RPS6KA1 (Homo sapiens) 6480464 Selenium results in increased expression of RPS6KA1 mRNA CTD PMID:19244175 selumetinib multiple interactions ISO Rps6ka1 (Mus musculus) 6480464 Doxorubicin promotes the reaction [AZD 6244 results in decreased phosphorylation of RPS6KA1 protein] CTD PMID:17876044 selumetinib decreases phosphorylation ISO Rps6ka1 (Mus musculus) 6480464 AZD 6244 results in decreased phosphorylation of RPS6KA1 protein CTD PMID:17876044 sirolimus increases phosphorylation ISO RPS6KA1 (Homo sapiens) 6480464 Sirolimus results in increased phosphorylation of RPS6KA1 protein CTD PMID:19151764 sirolimus multiple interactions ISO Rps6ka1 (Mus musculus) 6480464 Sirolimus results in increased phosphorylation of and results in increased activity of RPS6KA1 protein CTD PMID:19151764 sirolimus increases phosphorylation EXP 6480464 Sirolimus results in increased phosphorylation of RPS6KA1 protein CTD PMID:19151764 sirolimus affects localization ISO Rps6ka1 (Mus musculus) 6480464 Sirolimus affects the localization of RPS6KA1 protein CTD PMID:19151764 sodium arsenite decreases expression ISO RPS6KA1 (Homo sapiens) 6480464 sodium arsenite results in decreased expression of RPS6KA1 mRNA CTD PMID:12760830 sodium arsenite affects expression ISO RPS6KA1 (Homo sapiens) 6480464 sodium arsenite affects the expression of RPS6KA1 mRNA CTD PMID:34032870 sodium dichromate decreases expression ISO RPS6KA1 (Homo sapiens) 6480464 sodium bichromate results in decreased expression of RPS6KA1 mRNA CTD PMID:12760830 sodium dichromate increases expression ISO Rps6ka1 (Mus musculus) 6480464 sodium bichromate results in increased expression of RPS6KA1 mRNA CTD PMID:31558096 Soman increases expression EXP 6480464 Soman results in increased expression of RPS6KA1 mRNA CTD PMID:19281266 SU6656 decreases activity ISO RPS6KA1 (Homo sapiens) 6480464 SU 6656 results in decreased activity of RPS6KA1 protein CTD PMID:12534346 sulfadimethoxine increases expression EXP 6480464 Sulfadimethoxine results in increased expression of RPS6KA1 mRNA CTD PMID:30047161 sunitinib decreases activity ISO RPS6KA1 (Homo sapiens) 6480464 sunitinib results in decreased activity of RPS6KA1 protein CTD PMID:21906609 temozolomide increases expression ISO RPS6KA1 (Homo sapiens) 6480464 Temozolomide results in increased expression of RPS6KA1 mRNA CTD PMID:31758290 tert-butyl hydroperoxide increases phosphorylation ISO RPS6KA1 (Homo sapiens) 6480464 tert-Butylhydroperoxide results in increased phosphorylation of RPS6KA1 protein CTD PMID:17003459 tert-butyl hydroperoxide multiple interactions ISO RPS6KA1 (Homo sapiens) 6480464 U 0126 inhibits the reaction [tert-Butylhydroperoxide results in increased phosphorylation of RPS6KA1 protein] CTD PMID:17003459 testosterone multiple interactions ISO RPS6KA1 (Homo sapiens) 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of RPS6KA1 mRNA CTD PMID:21592394 testosterone increases expression ISO RPS6KA1 (Homo sapiens) 6480464 Testosterone results in increased expression of RPS6KA1 mRNA CTD PMID:21592394 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of RPS6KA1 mRNA and Carbon Tetrachloride results in increased expression of RPS6KA1 protein CTD PMID:17032414 and PMID:17805973 tetrachloromethane multiple interactions ISO Rps6ka1 (Mus musculus) 6480464 [Carbon Tetrachloride co-treated with Ethanol] results in increased expression of RPS6KA1 mRNA CTD PMID:30517762 titanium dioxide increases expression ISO Rps6ka1 (Mus musculus) 6480464 titanium dioxide results in increased expression of RPS6KA1 mRNA CTD PMID:23557971 toluene decreases expression ISO RPS6KA1 (Homo sapiens) 6480464 Toluene results in decreased expression of RPS6KA1 mRNA CTD PMID:26717081 toluene increases methylation ISO RPS6KA1 (Homo sapiens) 6480464 Toluene results in increased methylation of RPS6KA1 gene CTD PMID:26717081 tungsten decreases expression ISO Rps6ka1 (Mus musculus) 6480464 Tungsten results in decreased expression of RPS6KA1 mRNA CTD PMID:30912803 vitamin E multiple interactions ISO RPS6KA1 (Homo sapiens) 6480464 [Selenium co-treated with Vitamin E] results in increased expression of RPS6KA1 mRNA CTD PMID:19244175